US OptionsDetailed Quotes
RIGL250117C24000
- 0.30
- 0.000.00%
15min DelayClose Jan 7 16:00 ET
0.00High0.00Low
0.30Open0.30Pre Close0 Volume1 Open Interest24.00Strike Price0.00Turnover173.15%IV42.19%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier9DDays to Expiry0.30Extrinsic Value100Contract SizeAmericanOptions Type0.1397Delta0.0469Gamma56.97Leverage Ratio-0.0557Theta0.0005Rho7.96Eff Leverage0.0061Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
No comment yet